Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b29d19906729968302678e40b98910d0 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T436-104998 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T436-105831 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T436-144444 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-042 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-66 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06F19-3431 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7004 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16Z99-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G06F19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7004 |
filingDate |
2015-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f0b7766d78e52c8ee70b6fb2acff6f78 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bfa6ea583c0840a88cf109b4536c4468 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a171a12dc5c32e2050dde114eaa11313 |
publicationDate |
2015-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2015235002-A1 |
titleOfInvention |
Method and System to Provide Personalized Pharmaceutical Compositions and Dosages |
abstract |
Provided is a method for assessing cardiovascular risk in Metabolic Syndrome and Type 2 Diabetes patients. The method involves obtaining data from a Type 2 diabetes patient or a Metabolic Syndrome patient and determining a Fayad/Schentag index which includes a Glucose Supply Index (S) to an Insulin Demand Index (D) ratio. The Fayad/Schentag index is used in scoring cardiovascular risks of Metabolic Syndrome patients and for recommending and implementing therapeutic interventions that can be shown to lower cardiovascular risk |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021200896-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018007460-A1 |
priorityDate |
2009-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |